The THE DIFFERENCE OF PHYSICAL DIMENSION IN THE QUALITY OF LIVING ON PATIENTS OF DIABETES MELLITUS BETWEEN GIVING HYPERBARIC OXYGEN THERAPY 10 DAYS AND 5 DAYS

ABSTRACT Quality of life is the subjective perception of the individual to the physical, psychological, social, and environmental conditions experienced. The aim of the study was to analyze differences in the physical dimensions of the quality of life of diabetes mellitus patients between providing hyperbaric oxygen therapy 10 days and 5 days. This study used the quasy experiment method with the approach of pre post test with control group design. The population in the study was 882 people with a sample of 14 respondents divided into two groups. 7 respondents in the treatment group and 7 respondents in the control group. Sampling used was consecutive sampling technique. Data were analyzed using Paired t test and Independent t test. The results of the Paired t test statistic in the treatment group had differences in quality of life before and after 10 days of hyperbaric oxygen therapy, while the control group had no difference in quality of life before and after 5 days of hyperbaric oxygen therapy. The independent t test results were different after being given hyperbaric oxygen therapy 10 days and 5 days. It is expected that health workers can be used as a reference source and as a basis for determining nursing intervention in the management of diabetes, especially in the quality of life of diabetic patients.

Download Full-text

The THE DIFFERENCE OF PHYSICAL DIMENSION IN THE QUALITY OF LIVING ON PATIENTS OF DIABETES MELLITUS BETWEEN GIVING HYPERBARIC OXYGEN THERAPY 10 DAYS AND 5 DAYS

INTERNATIONAL JOURNAL OF NURSING AND MIDWIFERY SCIENCE (IJNMS) ◽

10.29082/ijnms/2018/vol2.iss03.186 ◽

2019 ◽

Vol 2 (03) ◽

pp. 296-303

Author(s):

Mufarika Mufarika ◽

Siti Aminah

Keyword(s):

Quality Of Life ◽

Diabetes Mellitus ◽

Hyperbaric Oxygen ◽

Hyperbaric Oxygen Therapy ◽

Oxygen Therapy ◽

T Test ◽

Control Group ◽

Before And After ◽

Paired T Test

Download Full-text

Avascular necrosis of the femoral head: Evaluation of hyperbaric oxygen therapy and quality of life

Undersea and Hyperbaric Medicine ◽

10.22462/10.12.2020.5 ◽

2020 ◽

pp. 561-569

Author(s):

Angeliki Chandrinou ◽

◽

Anna Korompeli ◽

Eirini Grammatopoulou ◽

Konstantina Gaitanou ◽

...

Keyword(s):

Quality Of Life ◽

Femoral Head ◽

Avascular Necrosis ◽

Hyperbaric Oxygen ◽

Hyperbaric Oxygen Therapy ◽

Oxygen Therapy ◽

Harris Hip Score ◽

Controlled Study ◽

Second Phase

Introduction: The treatment of avascular necrosis of the femoral head (AVNFH) is based on invasive (e.g., core decompression) and non-invasive methods (e.g., hyperbaric oxygen therapy – HBO2). The purpose of the present study is to evaluate the effect of HBO2 on the quality of life (QoL) of patients with AVNFH. Methods: This was a prospective observational non-controlled study of patients with AVNFH treated by HBO2. It was conducted, with the use of Steinberg scale, on 73 patients with AVNFH Stage I or II who were treated with HBO2. Patients’ QoL was assessed with EuroQol-5D-5L (EQ), Harris Hip Score (mHHS), MAHORN (MHOT), and VAS, in three different phases: before HBO2; after the completion of the first phase (20 HBO2 sessions, up to two months); and after the completion of the second phase (20 HBO2 sessions, up to two months after the first phase). A reassessment was made on the completion of each phase. Ratings were also made after the completion of each phase, over the first five months of follow-up. Results: All 73 patients (67.1% males, 32.9% females, mean age: 40.34, SD ± 9.99) participated in the study. Steinberg scale, mean EQ (F (1, 57) = 25.18, η2 = .306 and F (1, 43) = 43.402, η2 = .502); mHHS (F (1, 61) = 67.13, η2 = .524) and F (1, 43) = 31.84, η2 = .425); MHOT (F (1, 61) = 11.68, η2 = .161) and F (1, 43) = 98.01, η2 = .695); and VAS (F (1, 53) = 24.11, η2 = .313) and F (1, 39) = 45.61, η2 = .539), improved between the first and second measurements and between the second and third measurement accordingly (p < .01). Conclusions: HBO2 treatment does not induce alteration of quality of life and is well tolerated and accepted by patients.

Download Full-text